The store will not work correctly when cookies are disabled.
5-(3-Phenyl-allylidene)-2-selenoxo-dihydro-pyrimidine-4,6-dione
ID: ALA4164388
PubChem CID: 145960050
Max Phase: Preclinical
Molecular Formula: C13H10N2O2Se
Molecular Weight: 305.19
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1NC(=[Se])NC(=O)C1=C/C=C/c1ccccc1
Standard InChI: InChI=1S/C13H10N2O2Se/c16-11-10(12(17)15-13(18)14-11)8-4-7-9-5-2-1-3-6-9/h1-8H,(H2,14,15,16,17,18)/b7-4+
Standard InChI Key: PSXRNOYSPUSCPT-QPJJXVBHSA-N
Molfile:
RDKit 2D
18 19 0 0 0 0 0 0 0 0999 V2000
12.1071 -4.2787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8149 -3.8712 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5227 -4.2787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5227 -5.0978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8149 -5.5053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1071 -5.0978 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2346 -3.8712 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8149 -6.3244 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.3994 -3.8712 0.0000 Se 0 0 0 0 0 2 0 0 0 0 0 0
14.2346 -5.5053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9424 -5.0978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6501 -5.5053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3579 -5.0978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3579 -4.2787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0698 -3.8712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7776 -4.2787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7776 -5.0978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0698 -5.5053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
3 7 2 0
5 8 2 0
1 9 2 0
10 11 1 0
11 12 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
13 18 2 0
12 13 1 0
4 10 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 305.19 | Molecular Weight (Monoisotopic): 305.9907 | AlogP: ┄ | #Rotatable Bonds: ┄ |
Polar Surface Area: ┄ | Molecular Species: ┄ | HBA: ┄ | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): ┄ | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: ┄ | CX LogD: ┄ |
Aromatic Rings: ┄ | Heavy Atoms: ┄ | QED Weighted: ┄ | Np Likeness Score: ┄ |
References
1. Ramisetti SR, Pandey MK, Lee SY, Karelia D, Narayan S, Amin S, Sharma AK.. (2018) Design and synthesis of novel thiobarbituric acid derivatives targeting both wild-type and BRAF-mutated melanoma cells., 143 [PMID:29133035] [10.1016/j.ejmech.2017.11.006] |